查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2009413

靜脈輸液市場規模、佔有率、趨勢和預測：按類型、營養成分和地區分類，2026-2034年

Intravenous Solutions Market Size, Share, Trends and Forecast by Type, Nutrients, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

2025年全球靜脈輸液市場規模為163億美元。展望未來，IMARC Group預測，該市場將以4.30%的複合年成長率從2026年成長至2034年，到2034年達到238億美元。目前，北美市場佔據主導地位，預計2025年市佔率將超過40.7%。北美地區的成長主要得益於先進的醫療基礎設施、慢性病盛行率的上升以及老年人口的成長。

糖尿病、癌症和腎臟病等慢性疾病發生率的上升，增加了對靜脈輸液（IV）療法的需求。靜脈輸液療法可將液體、營養物質和藥物直接輸送到血液中。這些治療方法對於控制併發症和改善短期和長期照護機構中患者的預後至關重要。此外，老年人口的不斷成長，以及因脫水和免疫功能減弱等與老齡化相關的問題而需要重症監護的患者，也推動了對能夠有效解決這些問題的靜脈輸液療法的需求。同時，靜脈輸液療法的持續進步，包括精確控制的給藥系統、患者特異性營養配方和增強的安全措施，正在提高治療效果。這些進展使得能夠提供滿足患者個別需求的客製化解決方案，從而提升整體醫療服務品質。此外，因胃腸道疾病或其他嚴重健康狀況而無法經口進食的患者，也依賴靜脈輸液療法來獲得充足的營養。這種需求正在推動改良型腸外營養配方的研發和應用。

美國是該市場的重要組成部分。這主要源自於越來越多的手術需要靜脈輸液來維持水合作用、麻醉和術後恢復。此外，天災等事件會擾亂供應鏈，凸顯穩定供應靜脈輸液的重要性。為了應對這項挑戰，各公司正在擴大產能，並與監管機構和政府部門合作，以確保基本醫療產品的穩定供應。這些努力有助於穩定市場供應，維持醫療運營，並有效應對不斷成長的需求。 2024年，受颶風造成的生產中斷影響，貝朗公司宣布採取措施保障美國靜脈輸液的供應。該公司擴大了位於加州、佛羅裡達州和賓州的工廠的生產規模，使靜脈輸液產量提高了20%，靜脈輸液套裝的年產量增加了3000多萬套。此外，該公司還與聯邦機構合作，節約並重新分配關鍵庫存。

靜脈輸液市場趨勢：

慢性病增多

糖尿病、心臟病、癌症等慢性疾病以及需要靜脈輸液治療的嚴重發生率不斷上升，是推動市場成長的關鍵因素。根據國際糖尿病聯盟（IDF）統計，2021年英國有2,680,500名成年人被診斷出患有糖尿病。此外，根據美國疾病管制與預防中心（CDC）統計，2021年美國有1,777,566人被診斷出罹患癌症。同時，生活方式改變、環境因素和遺傳因素等全球趨勢也加劇了慢性疾病的發生，促進了市場成長。此外，各種急性和慢性疾病都需要將液體、營養素或藥物直接輸注到血液中。在這方面，靜脈輸液治療能夠精準地輸送維持生命的營養物質和藥物，促進患者快速康復。此外，它還能提供更快速、更可控的治療，尤其是在緊急情況下。

人口老化的過程

老年人口的成長對靜脈輸液治療市場的發展起了至關重要的作用。根據美國社區生活部 (ACL) 統計，2021 年至 2022 年間，美國約有 160 萬名 65 歲及以上的老年人。老年人更容易患上各種健康問題和慢性疾病，並且經常需要進行複雜的醫療程序，例如靜脈輸液治療，這推動了市場成長。此外，與年齡相關的生理變化，例如免疫功能減弱、器官功能下降老齡化，增加了老年人感染疾病和疾病的風險，也促進了市場成長。在此背景下，靜脈輸液治療對於確保輸送必要的液體、營養和藥物至關重要，從而確保治療的準確性和有效性。此外，靜脈輸液治療在糾正電解質失衡（包括鈉、鉀、鈣和鎂）方面的廣泛應用也是推動市場成長的另一個重要因素。

技術進步

醫療技術和靜脈製劑生產的進步正在推動市場成長。新興技術提高了靜脈治療的效率和安全性，同時促進了更個人化製劑的研發，以滿足每位患者的個別需求。此外，輸液幫浦和給藥系統的最新進展，使醫護人員能夠更精準、更有效地進行治療，也促進了市場擴張。同時，靜脈治療監測和給藥技術的進步，降低了併發症風險，改善了患者預後，也是推動市場成長的另一個動力。此外，大規模的研發投入，例如生物相容性、個人化治療策略和人工智慧（AI）等技術的引入，旨在改善醫療服務，也促進了市場成長。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球靜脈輸液市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場區隔：按類型
  • 市場區隔：依營養成分分類
  • 市場區隔：按地區
  • 市場預測
  • SWOT分析
  • 價值鏈分析
  • 波特五力分析

第6章 市場區隔：依類型

  • 部分腸外營養
  • 全靜脈營養

第7章 市場區隔：依營養素分類

  • 碳水化合物
  • 鹽和電解質
  • 礦物
  • 維他命
  • 胺基酸

第8章 市場區隔：依地區分類

  • 北美洲
  • 歐洲
  • 亞太地區
  • 中東和非洲
  • 拉丁美洲

第9章：靜脈輸液生產流程

第10章 競爭格局

  • 市場結構
  • 主要企業
  • 主要企業簡介
    • Ajinomoto
    • B. Braun Melsungen
    • Baxter International Inc.
    • Grifols
    • Otsuka Pharmaceutical
Product Code: SR112026A891

The global intravenous solutions market size was valued at USD 16.3 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 23.8 Billion by 2034, exhibiting a CAGR of 4.30% from 2026-2034. North America currently dominates the market, holding a market share of over 40.7% in 2025. The growth of the North American region is driven by advanced healthcare infrastructure, rising chronic disease prevalence, and increasing elderly population.

The rising incidence of chronic diseases such as diabetes, cancer, and kidney issues is driving the demand for intravenous (IV) therapy to provide hydration, nutrients, and medications straight into the bloodstream. These solutions are crucial for handling complications and enhancing patient outcomes in both short-term and long-term care environments. Additionally, the increasing elderly demographic, needing critical care because of age-related issues such as dehydration and compromised immune systems, is catalyzing the demand for IV solutions to tackle these problems efficiently. In addition to this, ongoing advancements in IV therapy, including precision-managed delivery systems, tailored nutrient mixes, and enhanced safety measures, are boosting the effectiveness of treatments. These developments enable customized solutions to address specific patient requirements, enhancing the overall quality of healthcare services. Moreover, patients who cannot eat by mouth, such as those with gastrointestinal issues or serious health conditions, depend on intravenous solutions for full nutrition. This need propels the creation and use of enhanced parenteral nutrition formulations.

The United States is a vital segment in the market, supported by the rising volume of surgeries conducted, which necessitate IV solutions to ensure hydration, administer anesthesia, and aid in post-operative recovery. In addition, occurrences such as natural disasters can interrupt supply chains, emphasizing the significance of a strong IV solution supply. In response, companies boost production capacities and partner with regulatory and government bodies to guarantee a steady supply of essential medical products. These efforts help stabilize market availability, maintain healthcare operations, and meet growing demand effectively. In 2024, B. Braun announced efforts to secure IV fluid supplies in the US after hurricanes disrupted production. The company ramped up manufacturing at facilities in California, Florida, and Pennsylvania, boosting IV fluid production by 20% and IV sets by over 30 million annually. They also collaborated with federal agencies to safeguard and redistribute critical inventory.

INTRAVENOUS SOLUTIONS MARKET TRENDS:

Increasing Prevalence of Chronic Conditions

The increased occurrence of chronic illnesses like diabetes, heart diseases, cancer, and severe conditions requiring IV therapies is a key element driving the growth of the market. As per the International Diabetes Federation, there were 2,680,500 adults diagnosed with diabetes in the UK in 2021. Moreover, the Centers for Disease Control and Prevention reported that in 2021, 1,777,566 individuals in the US population received a cancer diagnosis. Additionally, rising global trends like shifts in lifestyle, environmental influences, and genetic factors that contribute to a rise in chronic diseases serve as another catalyst for growth. Besides this, various chronic and acute conditions necessitate the direct infusion of fluids, nutrients, or medications into the bloodstream. In this regard, IV solutions enable accurate administration of vital nutrients and medications, promoting swift patient recovery. Moreover, they facilitate quicker and more regulated care, especially in urgent circumstances.

Growing Geriatric Population

The rising elderly population is playing a major role in the growth of the IV solutions market. The Administration for Community Living (ACL) reported that from 2021 to 2022, 1.6 million Americans were noted to be aged 65 or older. The increased vulnerability of the elderly to numerous health problems and chronic ailments, which frequently necessitate intricate medical treatments like IV therapy, is supporting the market growth. In addition, the existence of a compromised immune system, diminished organ performance, and other age-associated physiological alterations that increase the vulnerability of elderly individuals to infections and illnesses are contributing to the market growth. In this context, IV solutions are crucial for delivering necessary hydration, nutrients, and medications, making certain that the treatments are precise and effective. Additionally, the extensive use of IV solutions to correct imbalances in electrolytes like sodium, potassium, calcium, and magnesium is serving as another catalyst for growth.

Technological Advancements

Improvements in medical technology and the manufacturing of IV solutions are strengthening the growth of the market. In this regard, emerging technologies are facilitating the development of more tailored solutions that address particular patient requirements while improving the efficiency and safety of IV treatments. Moreover, the latest advancements in infusion pumps and delivery systems, enabling healthcare professionals to provide treatments with enhanced accuracy and control, are benefiting the market expansion. Furthermore, advancements in technology for overseeing and administering IV therapies to reduce the risk of complications and enhance patient outcomes are serving as another factor driving growth. In addition, considerable research and development (R&D) initiatives concentrating on biocompatibility, tailored treatment strategies, and the incorporation of technology like artificial intelligence (AI) to enhance care are propelling the market growth.

INTRAVENOUS SOLUTIONS INDUSTRY SEGMENTATION:

Analysis by Type:

  • Partial Parenteral Nutrition
  • Total Parenteral Nutrition

Total parenteral nutrition stands as the largest segment in 2025, holding 77.7% of the market share. Total parenteral nutrition (TPN) is leading the market as it addresses all the dietary needs of patients unable to consume or absorb sufficient food through normal digestive processes. Moreover, it has wide-ranging uses in several medical areas, such as oncology, gastroenterology, and intensive care units (ICUs). Besides this, the increasing prevalence of chronic illnesses like cancer and gastrointestinal disorders that require TPN for nutritional assistance is driving market expansion. Additionally, the rising use of TPN to address the nutritional requirements of patients undergoing significant surgical operations is driving market expansion. In addition, the advancements in TPN formulation and delivery technology, which provide safer and more individualized nutritional support, are contributing to the market growth.

Analysis by Nutrients:

  • Carbohydrates
  • Salts and Electrolytes
  • Minerals
  • Vitamins
  • Amino Acids

Amino acids lead the market with 36.8% of market share in 2025. Amino acids represent the largest segment, primarily due to their critical role in supporting protein synthesis, wound healing, and overall metabolic function. These essential nutrients are particularly vital for patients unable to consume adequate protein through oral or enteral routes, such as those undergoing major surgeries, suffering from trauma, or dealing with chronic illnesses like cancer and renal disorders. Amino acid-based IV solutions are widely used in TPN where they ensure the delivery of essential building blocks for maintaining muscle mass, immune function, and cellular repair. Advances in formulations tailored for specific patient needs, including pediatric and geriatric care, have further bolstered demand for amino acid solutions. Additionally, the increasing focus on personalized nutrition in clinical settings ensures that amino acids remain a cornerstone in intravenous therapy, making them the dominant choice among nutrients in the segment. This trend reflects their indispensable role in critical care and recovery.

Regional Analysis:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

In 2025, North America accounted for the largest market share of 40.7%. North America holds the biggest share in the market, supported by its sophisticated healthcare system and a significant incidence of chronic illnesses like diabetes, cancer, and heart diseases. The increasing elderly demographic in the area, who are more susceptible to dehydration and need essential medical care, greatly drives the need for intravenous therapies. Hospitals, outpatient clinics, and home care services depend on IV therapy to provide vital nutrients, medications, and hydration, thereby enhancing the market. Moreover, the extensive use of advanced technologies in IV solutions, including precision-controlled delivery systems, improves their application in intricate medical therapies. Collaborations among major industry stakeholders facilitate the sharing of resources, knowledge, and technologies to address increasing demand and enhance production efficiency. These collaborations also foster innovation in IV formulations, addressing evolving healthcare needs across the region. In November 2024, ICU Medical and Otsuka Pharmaceutical Factory announced a joint venture to enhance IV solutions manufacturing in North America, combining their expertise to produce 1.4 billion units annually. This partnership aims to strengthen supply chain resiliency and accelerate innovation in IV solutions for the region.

KEY REGIONAL TAKEAWAYS:

UNITED STATES INTRAVENOUS SOLUTIONS MARKET ANALYSIS

In North America, the United States accounted for 92.80% of the total market share. The increasing prevalence of chronic diseases across the nation such as diabetes, hypertension, and cancer are driving the demand for IV fluids. According to the International Diabetes Federation, in 2021, 237,306,100 number of the American population is suffering from diabetes. Additionally, according to the Centers for Disease Control and Prevention, between 2021 and 2023, 47.7% of the adults suffered from hypertension in USA. Moreover, the rate of hypertension was higher among men than among women. 50.8% of men and 44.6% of women had hypertension. In line with this, the growing number of elderly people who are often requiring IV treatments for hydration and nutrition is propelling the market for it. According to Censes Bureau, over the past century, from 1920 to 2020, the U.S. population aged 65 and above expanded at a rate nearly five times faster than the overall population. In 2020, the geriatric demographic reached 55.8 Million, accounting for 16.8% of the total U.S. population.

EUROPE INTRAVENOUS SOLUTIONS MARKET ANALYSIS

The intravenous solutions market across the European region is largely driven due to rising requirement of intravenous fluid administration for dehydration or illnesses like diarrhea or gastroenteritis, leading to significant demand for IV solutions especially among children. Additionally, the expanding healthcare infrastructure, especially in Eastern Europe, is contributing to the market growth. According to the European Commission, Germany boasts one of the largest hospital inpatient sectors in the EU, with 7.9 hospital beds per 1,000 people-significantly surpassing the EU average of 5.3 beds by 50%. In line with this, the increasing focus on providing nutritional support to patients who are unable to consume food orally is driving the demand for parenteral nutrition solutions across the region, which are being delivered intravenously. With the growing preference for home-based healthcare, especially in managing chronic conditions or post-surgical recovery, there is an increase in demand for home IV therapy solutions that are being delivered intravenously.

ASIA PACIFIC INTRAVENOUS SOLUTIONS MARKET ANALYSIS

Due to fast urbanization and rising healthcare requirements, especially in India and China, there is a strong demand for intravenous solutions in hospitals and clinics, particularly in rural and remote locations. For example, the International Trade Administration reports that by 2021, China set up a network of 36,570 hospitals, offering over 7.4 million beds and serving around 3.88 billion patient visits. Additionally, in nations like India and Southeast Asia, IV fluids are utilized for treating dehydration from infectious diseases like diarrhea and cholera, which are common in these areas. For example, the CDC states that travelers' diarrhea is the most prevalent illness associated with travel. These have the greatest risk in areas like Asia (excluding Japan and South Korea) and also the Middle East, Africa, Mexico, and Central and South America, consequently increasing the need for intravenous solutions.

LATIN AMERICA INTRAVENOUS SOLUTIONS MARKET ANALYSIS

In urban areas of Brazil, IV solutions are widely utilized in emergency departments, intensive care units, and trauma services. The rising incidence of chronic conditions such as diabetes and heart diseases is driving the need for IV solutions for hydration and medication delivery. The International Diabetes Federation reports that in 2021, 149,916,800 individuals in Brazil are affected by diabetes. In this context, the thriving medical tourism sector is promoting the utilization of IV solutions for numerous treatments, such as recovery after surgery and wellness therapies.

MIDDLE EAST AND AFRICA INTRAVENOUS SOLUTIONS MARKET ANALYSIS

Due to various factors, the need for intravenous solutions is increasing throughout the Middle East and Africa region. Increasing quantity of intravenous solutions are majorly used across the Gulf Cooperation Council (GCC) countries for the management of diabetes and renal diseases. According to the International Diabetes Federation, in 2021, 8,057,100 number of adults in the United Arab Emirates were diagnosed with diabetes. Moreover, 73 Million people are already diagnosed with diabetes across the MENA region. In line with this, intravenous solutions are increasingly used in conflict-affected and disaster-prone areas across the region for rehydration and medication.

COMPETITIVE LANDSCAPE:

Key players in the market are focusing on expanding their product portfolios through innovation and advanced formulations tailored to diverse medical needs. They are investing in research operations to improve solution stability, enhance nutrient delivery, and address specific patient conditions. Companies are also optimizing manufacturing processes to meet stringent regulatory requirements while ensuring cost-efficiency. Additionally, they are leveraging digital technologies for precision delivery and monitoring systems, aiming to improve patient outcomes. Market leaders are actively targeting emerging regions to capture growth opportunities and expand their user base. Strategic partnerships, mergers, and acquisitions are enhancing their worldwide presence and supply chain strengths. In May 2023, Intellego Technologies and HAI Solutions were pleased to announce a strategic partnership that aimed to enhance the quality and safety of intravenous (IV) vascular access. This partnership brought Intellego's patented UV-sensitive ink as an integral indicator into HAI Solutions' QIKcap(TM) technology, providing visible and reliable verification of IV port protection. The combined solution ensures confidence in the disinfection of needle-free connectors.

The report provides a comprehensive analysis of the competitive landscape in the intravenous solutions market with detailed profiles of all major companies, including:

  • Ajinomoto
  • B. Braun Melsungen
  • Baxter International Inc.
  • Grifols
  • Otsuka Pharmaceutical

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What are intravenous solutions?

2. How big is the global intravenous solutions market?

3. What is the expected growth rate of the global intravenous solutions market during 2026-2034?

4. What are the key factors driving the global intravenous solutions market?

5. What is the leading segment of the global intravenous solutions market based on type?

6. What is the leading segment of the global intravenous solutions market based on nutrients?

7. What are the key regions in the global intravenous solutions market?

8. Who are the key players/companies in the global intravenous solutions market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Intravenous Solutions Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Type
  • 5.5 Market Breakup by Nutrients
  • 5.6 Market Breakup by Region
  • 5.7 Market Forecast
  • 5.8 SWOT Analysis
    • 5.8.1 Overview
    • 5.8.2 Strengths
    • 5.8.3 Weaknesses
    • 5.8.4 Opportunities
    • 5.8.5 Threats
  • 5.9 Value Chain Analysis
    • 5.9.1 Overview
    • 5.9.2 Research and Development
    • 5.9.3 Raw Material Procurement
    • 5.9.4 Manufacturing
    • 5.9.5 Marketing
    • 5.9.6 Distribution
    • 5.9.7 End-Use
  • 5.10 Porters Five Forces Analysis
    • 5.10.1 Overview
    • 5.10.2 Bargaining Power of Buyers
    • 5.10.3 Bargaining Power of Suppliers
    • 5.10.4 Degree of Competition
    • 5.10.5 Threat of New Entrants
    • 5.10.6 Threat of Substitutes

6 Market Breakup by Type

  • 6.1 Partial Parenteral Nutrition
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Total Parenteral Nutrition
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Nutrients

  • 7.1 Carbohydrates
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Salts and Electrolytes
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Minerals
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Vitamins
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Amino Acids
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Europe
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Asia Pacific
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Middle East and Africa
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Latin America
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Intravenous Solutions Manufacturing Process

  • 9.1 Product Overview
  • 9.2 Raw Material Requirements
  • 9.3 Manufacturing Process
  • 9.4 Key Success and Risk Factors

10 Competitive Landscape

  • 10.1 Market Structure
  • 10.2 Key Players
  • 10.3 Profiles of Key Players
    • 10.3.1 Ajinomoto
      • 10.3.1.1 Company Overview
      • 10.3.1.2 Description
      • 10.3.1.3 Product Portfolio
      • 10.3.1.4 Financials
      • 10.3.1.5 SWOT Analysis
    • 10.3.2 B. Braun Melsungen
      • 10.3.2.1 Company Overview
      • 10.3.2.2 Description
      • 10.3.2.3 Product Portfolio
      • 10.3.2.4 Financials
      • 10.3.2.5 SWOT Analysis
    • 10.3.3 Baxter International Inc.
      • 10.3.3.1 Company Overview
      • 10.3.3.2 Description
      • 10.3.3.3 Product Portfolio
      • 10.3.3.4 Financials
      • 10.3.3.5 SWOT Analysis
    • 10.3.4 Grifols
      • 10.3.4.1 Company Overview
      • 10.3.4.2 Description
      • 10.3.4.3 Product Portfolio
      • 10.3.4.4 Financials
      • 10.3.4.5 SWOT Analysis
    • 10.3.5 Otsuka Pharmaceutical
      • 10.3.5.1 Company Overview
      • 10.3.5.2 Description
      • 10.3.5.3 Product Portfolio

List of Figures

  • Figure 1: Global: Intravenous Solutions Market: Major Drivers and Challenges
  • Figure 2: Global: Intravenous Solutions Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Intravenous Solutions Market: Breakup by Type (in %), 2025
  • Figure 4: Global: Intravenous Solutions Market: Breakup by Nutrients (in %), 2025
  • Figure 5: Global: Intravenous Solutions Market: Breakup by Region (in %), 2025
  • Figure 6: Global: Intravenous Solutions Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 7: Global: Intravenous Solutions Industry: SWOT Analysis
  • Figure 8: Global: Intravenous Solutions Industry: Value Chain Analysis
  • Figure 9: Global: Intravenous Solutions Industry: Porter's Five Forces Analysis
  • Figure 10: Global: Intravenous Solutions (Partial Parenteral Nutrition) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Intravenous Solutions (Partial Parenteral Nutrition) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Intravenous Solutions (Total Parenteral Nutrition) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Intravenous Solutions (Total Parenteral Nutrition) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Intravenous Solutions (Carbohydrates) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Intravenous Solutions (Carbohydrates) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Intravenous Solutions (Salts and Electrolytes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Intravenous Solutions (Salts and Electrolytes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Intravenous Solutions (Minerals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Intravenous Solutions (Minerals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Intravenous Solutions (Vitamins) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Intravenous Solutions (Vitamins) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Intravenous Solutions (Amino Acids) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Intravenous Solutions (Amino Acids) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: North America: Intravenous Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: North America: Intravenous Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Europe: Intravenous Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Europe: Intravenous Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Asia Pacific: Intravenous Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Asia Pacific: Intravenous Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Middle East and Africa: Intravenous Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Middle East and Africa: Intravenous Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Latin America: Intravenous Solutions Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Latin America: Intravenous Solutions Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: Intravenous Solutions Manufacturing: Detailed Process Flow

List of Tables

  • Table 1: Global: Intravenous Solutions Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Intravenous Solutions Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Intravenous Solutions Market Forecast: Breakup by Nutrients (in Million USD), 2026-2034
  • Table 4: Global: Intravenous Solutions Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 5: Intravenous Solutions: Raw Material Requirements
  • Table 6: Global: Intravenous Solutions Market: Competitive Structure
  • Table 7: Global: Intravenous Solutions Market: Key Players